Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 26, 2007

View Archived Issues

Avexa reports progress with apricitabine

NovaCal changes name to NovaBay

Plethora seeks clearance to begin phase III for PSD-502 in premature ejaculation

TorreyPines and Eisai extend Alzheimer's disease collaboration

Peregrine licensee begins phase I trial with TNT cancer agent

New phase I trial studies L-annamycin in pediatric ALL and AML

CUV-1647 significantly delays onset of erythropoietic protoporphyria pain

Development of AOD-9604 in obesity terminated following phase IIb results

Antitumor activity following GVAX immunotherapy + ipilimumab

Incyte updates pipeline advances

Phase III findings for Cimzia in rheumatoid arthritis

CureDM reports diabetes preclinical milestones

Valeant files IND for Cesamet in chemotherapy-induced neuropathic pain

Rosiglitazone linked to increased incidence of fractures in female patients

Novel synthetic diazonamide A analogue shows promise in preclinical studies

Therapeutic potential for prolactin inhibition in postpartum cardiomyopathy

(-)-Epigallocatechin-3-gallate lipophilic analogue shows antidiabetic activity in vitro and in vivo

Roche suspends recruitment in phase II CERA study

Avastin recommended for approvals in Japan, E.U.

Approvable letter for Galvus

Vyvanse approved for ADHD

Xeloda recommended for E.U. approval for advanced gastric cancer

Sebivo recommended for approval in E.U. for chronic hepatitis B

Recent patents disclose novel antiinfective agents

Novel agents for HIV infection reported in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...